As shown in Figure 4, which depicts laboratory values since 2020, a typical pattern of secondary hyperparathyroidism was evident, characterized by declining calcium levels as the disease advances, in contrast to increasing phosphorus and parathyroid hormone levels. This evidence concerns the gene PTH and secondary hyperparathyroidism.